Cargando…
Quality by Design–Applied Liquid Chromatography-Tandem Mass Spectrometry Determination of Enzalutamide Anti-Prostate Cancer Therapy Drug in Spiked Plasma Samples
This research article presents the Quality by Design (QbD)–finalised conditions for a method that uses liquid chromatography-tandem mass spectrometry for the determination of concentration of enzalutamide (ENZ), an atypical anticancer drug, in a drug formulation and in spiked plasma samples. Critica...
Autores principales: | Sankar, ASK, Palani, Shanmugasundaram, Velayudham, Ravichandiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576540/ https://www.ncbi.nlm.nih.gov/pubmed/28874884 http://dx.doi.org/10.1177/1177390117726776 |
Ejemplares similares
-
Determination of chloramphenicol in meat samples using liquid chromatography–tandem mass spectrometry
por: Akter Mou, Salma, et al.
Publicado: (2021) -
Determination of Mebudipine in Human Plasma by Liquid Chromatography–tandem Mass Spectrometry
por: Asgari, Arezoo, et al.
Publicado: (2015) -
Establishment to measure oxycodone in plasma with liquid chromatography–tandem mass spectrometry
por: Ito, Suguru, et al.
Publicado: (2022) -
Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022) -
Liquid chromatography–tandem mass spectrometry for clinical diagnostics
por: Thomas, Stefani N., et al.
Publicado: (2022)